Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Immunological Reviews|October 1, 1989
Surface molecules involved in the activation and regulation of T or natural killer lymphocytes in humansA Moretta, E Ciccone, G Pantaleo, et al.
Antiviral Therapy|July 19, 2005
Study on mutations and antiretroviral therapy (SMART): preliminary resultsN Gianotti, F Moretti, G Tambussi, et al.
Scandinavian Journal of Infectious Diseases|March 10, 2001
Acute self-limiting hepatitis C after possible sexual exposure: sequence analysis of the E-2 region of the infected patient and sexual partnerG Morsica, G Sitia, M T Bernardi, et al.
The Journal of Experimental Medicine|July 1, 1988
A monoclonal antibody specific for a common determinant of the human T cell receptor gamma/delta directly activates CD3+WT31- lymphocytes to express their functional program(s)E Ciccone, S Ferrini, C Bottino, et al.
The Journal of Experimental Medicine|April 1, 1988
Antigen recognition by human T cell receptor gamma-positive lymphocytes. Specific lysis of allogeneic cells after activation in mixed lymphocyte cultureE Ciccone, O Viale, C Bottino, et al.
Journal of Clinical & Laboratory Immunology|April 1, 1988
T-lymphocyte subsets and delayed type hypersensitivity as classification parameters for HIV infection among drug-addictsA Lazzarin, C Negri, G Tambussi, et al.
AIDS Research and Human Retroviruses|March 1, 1996
Cytokines and soluble receptor changes in the transition from primary to early chronic HIV type 1 infectionW Barcellini, G P Rizzardi, G Poli, et al.
Journal of Biological Regulators and Homeostatic Agents|January 1, 1997
Increased plasma levels of the C-C chemokine RANTES in patients with primary HIV-1 infectionM S Malnati, G Tambussi, E Clerici, et al.
Journal of Biological Regulators and Homeostatic Agents|January 1, 1997
Soluble CD30, tumour necrosis factor (TNF)-alpha, and TNF receptors in primary HIV-1 infection: relationship with HIV-1, RNA, clinical outcome and early antiviral therapyG P Rizzardi, G Tambussi, W Barcellini, et al.
The Journal of Experimental Medicine|July 1, 1990
Specific recognition of human CD3-CD16+ natural killer cells requires the expression of an autosomic recessive gene on target cellsE Ciccone, D Pende, O Viale, et al.
Pageof 8